In a previous study, LAIR2 was identified as a potential predictor of HDACi resistance in CTCL, as LAIR2 was significantly higher in skin biopsies and blood from patients with HDACi-resistant MF/SS. Here, LAIR2 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.